A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer / 대한비뇨기과학회지
Korean Journal of Urology
; : 195-199, 1981.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-28021
Responsible library:
WPRO
ABSTRACT
Primary transitional cell carcinoma of the bladder was treated with prophylactic and therapeutic Intravesical thiotepa in 7 cases. In 5 cases of stage A tumor, postoperative follow up was averaged 10.8 months and 4 cases were tumor free (80%). In 2 cases of infiltrating tumor, the instillation was not effective. Thiotepa can be given safely in the 7 days post-operative period and no leukopenia and bladder irritation symptoms were occurred.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Urinary Bladder
/
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
/
Follow-Up Studies
/
Thiotepa
/
Leukopenia
Type of study:
Observational study
/
Prognostic study
Language:
Korean
Journal:
Korean Journal of Urology
Year:
1981
Document type:
Article